A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumors. Their findings, published in the journal ACS Applied Materials & Interfaces, have indicated that regular urine tests could help early detection and treat ... more
AI performs as well as medical specialists in analyzing lung disease
A Nagoya University research group has developed an AI algorithm that accurately and quickly diagnoses idiopathic pulmonary fibrosis, a lung disease. The algorithm makes its diagnosis based only on information from non-invasive examinations, including lung images and medical information collected during daily medical care.
Doctors have waited a long time for an early means of diagnosing idiopathic pulmonary fibrosis, a potentially fatal disease that can scar a person’s lungs. Except for drugs that can delay the disease’s progression, established therapies do not exist. Since doctors face many difficulties diagnosing the disease, they often have to request a specialist diagnosis. In addition, many of the diagnostic techniques, such as lung biopsy, are highly invasive. These investigative measures may exacerbate the disease, increasing a patient's risk of dying.
Taiki Furukawa, Assistant Professor of the Nagoya University Hospital, in collaboration with RIKEN and Tosei General Hospital, has developed a new technology to diagnose idiopathic pulmonary fibrosis. Using artificial intelligence (AI), the group analyzed medical data from patients in Tosei General Hospital’s interstitial pneumonia treatment facility, collected during normal care. They found that their AI diagnosed idiopathic pulmonary fibrosis with a similar level of accuracy as a human specialist. They published their results in the journal Respirology.
Despite finding that their AI performed just as well as experts, the team stress that they do not see it as replacing medical professionals. Instead, they hope that specialists will use AI in medical treatment to ensure that they do not miss opportunities for early treatment. Its use would also avoid invasive procedures, such as lung biopsies, which could save lives.
“Idiopathic pulmonary fibrosis has a very poor prognosis among lung diseases”, Furukawa says. “It has been difficult to diagnose even for general respiratory physicians. The diagnostic AI developed in this study would allow any hospital to get a diagnosis equivalent to that of a specialist. For idiopathic pulmonary fibrosis, the developed diagnostic AI is useful as a screening tool and may lead to personalized medicine by collaborating with medical specialists.”
Furukawa is excited about the possibilities: “The practical application of diagnostic AI and collaborative diagnosis with specialists may lead to a more accurate diagnosis and treatment. We expect it to revolutionize medical care.”
- idiopathic pulmonar…
- Nagoya University
- lung diseases
- artificial intelligence
Knowing how to build nanosized assemblies of polymers (long molecular chains) holds the key to improving a broad range of industrial processes, from the production of nanofibers, filters, and new materials to the manufacture of low-energy, nanoscale circuits and devices. A recent paper in N ... more
- 1Miniaturized Lab-on-a-Chip for real-time Chemical Analysis of Liquids
- 2Organic thin-film sensors for light-source analysis and anti-counterfeiting applications
- 3A new era of early cancer detection with blood test may change cancer screening paradigms
- 4Beckman Coulter Life Sciences acquires Dublin biotech start-up
- 5Less risk, less costs: Portable spectroscopy devices could soon become real
- 6Pumping up the music of molecules
- 7Mobile phone app accurately detects COVID-19 infection in people’s voices with the help of artificial intelligence
- 8Early Detection by Tango
- 9Pharmacoscopy: Next-Generation Microscopy
- 10How does your computer smell?
- Damage-free way to gauge the health of next-gen batteries for electric vehicles
- Evident to accelerate its growth and innovation
- White, red, and blue signals alert you to dangerous germs!
- AI performs as well as medical specialists in analyzing lung disease
- Detection of cancer biomarkers from blood samples using nanopore-based DNA computing technology